Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Barrett Esophagus 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Lung Diseases 1Hypoxia 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Breast Neoplasm Female 1Adenocarcinoma of Lung 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Diagnostic Imaging × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT02640586 2023-06-22

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

Peking University Cancer Hospital & Institute

Phase NA Unknown
1,614 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡